Global Knee Replacement Market Size, Share, Growth, Trends, Industry Analysis & Forecast 2026–2034

Knee Replacement Market Trends

The global knee replacement market is projected to experience steady growth, expanding from US$ 13.82 billion in 2025 to US$ 21.48 billion by 2034, at a CAGR of 5.02% during the forecast period from 2026 to 2034. Market growth is primarily driven by the increasing prevalence of osteoarthritis and other degenerative joint disorders, a rapidly expanding elderly population, the rising incidence of sports-related injuries, and continuous advancements in implant materials and surgical technologies. In addition, growing awareness of joint replacement procedures, improved access to healthcare services, and the increasing adoption of minimally invasive and robotic-assisted surgical techniques are expected to support the long-term expansion of the global market.

Knee Replacement and its demands worldwide

Knee replacement, commonly known as knee arthroplasty, is a surgical procedure that involves replacing damaged or worn knee joint surfaces with artificial implants manufactured from durable materials such as metal alloys, ceramic components, and high-performance polyethylene. The primary objective of the procedure is to relieve chronic pain, restore joint function, improve mobility, and enhance the overall quality of life for patients affected by advanced osteoarthritis, rheumatoid arthritis, traumatic knee injuries, avascular necrosis, and other degenerative musculoskeletal conditions. Depending on the extent of joint damage, patients may undergo either total knee replacement (TKR), in which the entire knee joint is replaced, or partial knee replacement (PKR), which replaces only the damaged compartment while preserving healthy bone and surrounding tissues. Technological advancements in implant design, robotic-assisted surgery, computer-assisted navigation, and minimally invasive surgical approaches have significantly improved procedural accuracy, shortened recovery periods, enhanced clinical outcomes, and increased implant longevity.

The demand for knee replacement procedures has increased considerably over the past decade, driven by demographic shifts and the growing burden of musculoskeletal disorders worldwide. Factors such as population aging, increasing obesity rates, sedentary lifestyles, and greater participation in sports and recreational activities have contributed to a rising number of individuals experiencing cartilage deterioration, knee degeneration, and ligament injuries. North America and Europe continue to account for a significant share of the global market due to their well-established healthcare infrastructure, high healthcare expenditure, favorable reimbursement policies, and widespread awareness of joint replacement treatments. Meanwhile, emerging economies across Asia-Pacific, Latin America, and the Middle East are witnessing robust market growth, supported by improving healthcare infrastructure, rising disposable incomes, and greater access to advanced orthopedic services. Ongoing innovations in implant materials, digital surgical planning, robotic-assisted systems, and personalized orthopedic solutions are expected to further strengthen market growth, positioning knee replacement surgery as one of the most effective long-term treatments for pain relief, mobility restoration, and improved patient outcomes worldwide.

Growth Drivers

Rising Prevalence of Osteoarthritis and Degenerative Joint Disorders

The increasing prevalence of osteoarthritis (OA) and other degenerative joint disorders remains one of the primary factors driving the growth of the global knee replacement market. According to global health estimates, approximately 528 million people were living with osteoarthritis in 2019, representing an increase of 113% compared with 1990. Osteoarthritis accounts for nearly 50% of all musculoskeletal disorders, with knee osteoarthritis being the most common form worldwide. The disease burden continues to rise with advancing age and increasing obesity levels, making it one of the leading causes of disability globally. In the Global Burden of Disease (GBD) 2010 study, hip and knee osteoarthritis ranked among the leading causes of years lived with disability (YLDs). Population aging significantly increases the risk of cartilage degeneration, chronic knee pain, and impaired mobility, making knee replacement surgery an effective long-term treatment option. Rising obesity rates further accelerate joint deterioration by increasing mechanical stress on the knee, while sports-related injuries and post-traumatic arthritis among younger individuals are also contributing to higher procedural volumes. As conservative treatment options such as pain medications, physiotherapy, and lifestyle modifications become less effective in advanced disease stages, a growing number of patients are opting for knee replacement procedures to restore mobility and improve quality of life.

Advancements in Implant Design and Surgical Technologies

Continuous technological innovation in implant materials, prosthetic design, and surgical techniques is significantly supporting the expansion of the knee replacement market. Modern knee implants are designed with enhanced biocompatibility, improved durability, and superior anatomical compatibility, contributing to longer implant longevity and improved functional outcomes. The adoption of robotic-assisted surgical systems, computer-assisted navigation, and patient-specific instrumentation has substantially improved surgical precision while reducing complications and improving implant alignment. In addition, minimally invasive surgical techniques have reduced incision sizes, minimized blood loss, shortened hospital stays, and accelerated postoperative recovery. These technological advancements have increased confidence among both orthopedic surgeons and patients, encouraging greater adoption of knee replacement procedures, particularly among younger and physically active individuals seeking durable long-term outcomes. In December 2025, Even Healthcare successfully performed its first robotic-assisted knee replacement surgery at its newly established hospital in Bengaluru. The achievement highlights the company’s commitment to integrating advanced surgical technologies and developing a technology-driven healthcare model focused on improving clinical outcomes.

Growing Demand for Enhanced Mobility and Quality of Life

Increasing expectations for improved mobility, independence, and overall quality of life are further driving demand for knee replacement procedures worldwide. Patients are increasingly seeking long-term pain relief and the ability to maintain active lifestyles well into older age. High procedural success rates, improved implant performance, shorter recovery periods, and advancements in rehabilitation protocols have strengthened confidence in knee replacement surgery among both patients and healthcare professionals. Greater public awareness through healthcare providers, digital health platforms, and patient education initiatives has also contributed to higher acceptance of joint replacement procedures. In addition, improving access to specialized orthopedic care, expanding healthcare infrastructure, and the growth of medical tourism in emerging economies are supporting market expansion. As healthy aging and functional independence become key healthcare priorities, knee replacement surgery continues to gain recognition as an effective solution for restoring mobility and enhancing long-term patient well-being.

Knee Replacement Product Launches Worldwide

• July 2023 – Tirobot Recon Robotic System (China)
  Beijing Tinavi Medical Technologies Co., Ltd. received approval from China’s National Medical Products Administration (NMPA) for its Tirobot Recon robotic system for total knee arthroplasty (TKA), expanding its orthopedic robotics portfolio.
• November 22, 2024 (FDA Approval) – Oxford™ Cementless Partial Knee System (United States)
  Zimmer Biomet received U.S. FDA approval for the Oxford™ Cementless Partial Knee System, designed for unicompartmental knee replacement without bone cement, enabling shorter surgical times and faster recovery.
• April 14, 2025 – Evolution® Medial-Pivot Knee (India)
  MicroPort Orthopedics launched its Evolution® Medial-Pivot Knee implant in India, offering enhanced flexion stability, anatomical motion, and long-term wear performance for total knee replacement patients.
• April 2025 – Freedom® Total Knee with TMINI® Robotic System (United States)
  THINK Surgical, Inc. announced the first clinical use of Maxx Orthopedics’ Freedom® Total Knee implant with the TMINI® Miniature Robotic System, expanding robotic-assisted knee replacement capabilities.
• June 2025 – VELYS™ Robotic-Assisted Solution for UKA (Europe)
  Johnson & Johnson MedTech (DePuy Synthes) performed the first European procedures using the VELYS™ Robotic-Assisted Solution for Unicompartmental Knee Arthroplasty (UKA), extending robotic applications in partial knee replacement.
• June 2025 – VELYS™ Robotic Knee Replacement at TORC Ortho Care (India)
  TORC Ortho Care introduced Johnson & Johnson’s VELYS™ Robotic-Assisted Knee Replacement System in Madurai, improving precision, implant alignment, and patient recovery.
• December 2025 – Next-Generation Mako TKA 2.0 (India)
  Fortis Hospital, Nagarbhavi (Bengaluru) launched Stryker’s Next-Generation Mako Robotic System (Mako TKA 2.0) featuring AI-enabled surgical planning and CT-based 3D modeling for knee replacement surgery.
• December 2025 – Robotic Knee Replacement Program (India)
  Even Healthcare successfully completed its first robotic-assisted knee replacement surgery at its Bengaluru hospital, marking the rollout of its advanced orthopedic robotic surgery program.
• Early 2026 – Smart Knee Implant with Remote Monitoring (United States)
  Zimmer Biomet introduced a smart knee implant integrated with remote patient monitoring technology, enabling clinicians to track recovery metrics such as range of motion, walking activity, and rehabilitation progress through a connected mobile application.
• 2026 – Dual-Mobility Joint Implant Advancements (Global)
  Manufacturers including Stryker and Johnson & Johnson continued expanding advanced joint replacement technologies with newer implant designs focused on improving stability, reducing complications, and enhancing long-term clinical outcomes.

Challenges

High Cost of Surgery and Limited Accessibility

The high cost associated with knee replacement procedures remains a major challenge limiting market growth, particularly across low- and middle-income countries. Total treatment expenses, including implant costs, hospitalization, surgical expertise, diagnostic evaluations, and postoperative rehabilitation, often create significant financial barriers for patients. Even in developed healthcare systems, reimbursement limitations, insurance coverage restrictions, and high out-of-pocket expenses can delay or reduce access to surgery. Furthermore, public healthcare systems in several countries continue to experience budgetary constraints and extended waiting periods for elective orthopedic procedures, restricting timely patient treatment. These affordability and accessibility challenges continue to hinder broader adoption of knee replacement surgery worldwide.

Surgical Risks and Postoperative Complications

Despite significant advancements in surgical techniques and implant technologies, knee replacement procedures continue to involve certain clinical risks. Potential complications include postoperative infections, implant loosening, blood clots, joint stiffness, reduced range of motion, and the need for revision surgery in some patients. Concerns regarding surgical risks, lengthy rehabilitation periods, and recovery time may discourage eligible patients from undergoing the procedure. Clinical outcomes can also vary depending on factors such as patient health status, surgeon experience, implant quality, and adherence to rehabilitation protocols. Consequently, minimizing complications, improving long-term implant performance, and ensuring consistent clinical outcomes remain ongoing priorities for healthcare providers, medical device manufacturers, and orthopedic specialists.

Product Type Analysis

Partial Knee Replacement

Partial knee replacement (PKR) involves replacing only the damaged compartment of the knee joint while preserving the healthy bone, cartilage, and ligaments. The procedure is primarily recommended for patients with localized osteoarthritis and intact surrounding joint structures. Demand for partial knee replacement is increasing due to its minimally invasive nature, shorter hospitalization, faster recovery, and improved preservation of natural knee function. Compared with total knee replacement, patients generally experience reduced postoperative pain, quicker rehabilitation, and an earlier return to daily activities. Advancements in diagnostic imaging, robotic-assisted surgery, computer navigation, and implant technologies have further enhanced surgical accuracy and clinical outcomes. The growing preference for tissue-preserving orthopedic procedures, particularly among younger and physically active patients, continues to support the expansion of this market segment.

Revision Knee Replacement

The revision knee replacement market comprises secondary surgical procedures performed to replace or repair failed primary knee implants. Growth in this segment is closely linked to the increasing number of primary knee replacement surgeries performed worldwide. Common reasons for revision procedures include implant wear, aseptic loosening, infection, instability, mechanical failure, and periprosthetic fractures. Revision surgeries are generally more complex than primary procedures and require specialized implants, advanced surgical planning, and highly experienced orthopedic surgeons. Continuous improvements in implant materials, modular prosthetic systems, fixation technologies, and surgical techniques have enhanced the success rates of revision procedures. Furthermore, increasing life expectancy and the growing number of younger patients undergoing primary knee replacement are expected to contribute to sustained demand for revision surgeries over the coming years.

Implant Type Analysis

Fixed Bearing Knee Replacement

Fixed bearing knee replacement implants remain the most widely adopted implant design within the global knee replacement market. These systems utilize a polyethylene insert that is securely fixed to the tibial component, providing excellent stability, durability, and long-term clinical performance. Their extensive clinical history, cost-effectiveness, and suitability for a broad patient population have contributed to their continued market leadership. Fixed bearing implants are particularly recommended for older adults and individuals with relatively lower activity levels, where implant longevity and reliable performance are key treatment objectives. Ongoing advancements in highly cross-linked polyethylene materials, implant geometry, and surface engineering have significantly reduced wear rates while improving long-term outcomes. Strong surgeon familiarity and widespread product availability continue to support the dominance of this segment.

Mobile Bearing Knee Replacement

Mobile bearing knee replacement systems are designed with a polyethylene insert that allows controlled rotational movement, more closely replicating the natural biomechanics of the knee joint while reducing implant wear. These implants are particularly suited for younger, more active patients seeking greater joint mobility and long-term implant durability. Increasing demand for personalized orthopedic treatments and motion-preserving implant technologies is supporting growth within this segment. Although mobile bearing implants generally require greater surgical precision and involve higher procedural costs, their potential benefits—including improved range of motion, reduced polyethylene wear, and enhanced implant longevity—continue to encourage adoption. Technological advancements in implant engineering and surgical techniques are expected to further drive market growth.

End User Analysis

Knee Replacement Hospitals

Hospitals represent the largest end-user segment in the global knee replacement market owing to their comprehensive healthcare infrastructure, multidisciplinary orthopedic teams, and ability to manage both routine and highly complex surgical procedures. Large multi-specialty hospitals and academic medical centers perform a significant volume of primary, partial, and revision knee replacement surgeries each year. Access to advanced diagnostic imaging, robotic-assisted surgical platforms, intensive postoperative care, and comprehensive rehabilitation services further reinforces the dominance of hospitals within the market. In addition, favorable reimbursement policies, government healthcare funding, and high patient confidence continue to support hospital-based knee replacement procedures worldwide.

Knee Replacement Orthopedic Clinics

Orthopedic clinics are emerging as an increasingly important care setting for knee replacement procedures, particularly for elective surgeries and minimally invasive interventions. These specialized centers offer focused orthopedic expertise, shorter waiting times, personalized treatment plans, and cost-effective surgical care compared with traditional hospital settings. Advances in outpatient surgical techniques, enhanced recovery protocols, and improved anesthesia methods have enabled many carefully selected patients to undergo knee replacement procedures safely in specialized orthopedic clinics. Growing patient preference for dedicated orthopedic care and streamlined treatment pathways continues to support the expansion of this segment.

Country Analysis

United States Knee Replacement

The United States remains the largest and most technologically advanced knee replacement market globally, supported by a high prevalence of osteoarthritis, an aging population, and a well-established healthcare system. Millions of knee replacement procedures are performed annually, driven by increasing disease burden, early diagnosis, widespread awareness, and broad access to advanced orthopedic care. Rising obesity rates, sports-related injuries, and active lifestyles among older adults continue to contribute to growing procedural demand. The U.S. market is characterized by rapid adoption of innovative technologies, including robotic-assisted surgery, computer-assisted navigation, artificial intelligence-enabled surgical planning, and patient-specific implant systems, all of which enhance surgical precision and clinical outcomes. Comprehensive reimbursement through public and private insurance programs further supports procedure volumes, although treatment costs remain a consideration for some patients.

In April 2025, THINK Surgical, Inc. announced the first clinical use of Maxx Orthopedics’ Freedom Total Knee implant utilizing the TMINI® Miniature Robotic System at Coastal Orthopedics Surgery Center in Bradenton, Florida, demonstrating continued innovation in robotic-assisted knee replacement surgery.

United Kingdom Knee Replacement

The United Kingdom has a mature knee replacement market supported by a robust public healthcare system and increasing demand for orthopedic services. The National Health Service (NHS) performs a substantial number of knee replacement procedures annually, particularly for elderly patients affected by osteoarthritis and mobility-related disorders. Population aging and increasing life expectancy continue to drive procedural volumes across the country. Technological advancements in implant design, minimally invasive surgery, robotic-assisted procedures, and enhanced recovery programs have improved surgical outcomes while reducing hospital stays. However, extended waiting times within the public healthcare system have encouraged a growing number of patients to seek treatment through private healthcare providers, further contributing to market expansion.

In June 2025, Johnson & Johnson MedTech announced the first European clinical procedures using its VELYS Robotic-Assisted Solution for unicompartmental knee arthroplasty (UKA), representing a significant advancement in robotic-assisted orthopedic surgery across the region.

China Knee Replacement

China represents one of the fastest-growing knee replacement markets worldwide, driven by its large aging population, rising prevalence of osteoarthritis, and increasing incidence of lifestyle-related joint disorders and traumatic injuries. Ongoing healthcare reforms, expanded medical insurance coverage, and substantial government investments in hospital infrastructure have significantly improved access to advanced orthopedic procedures, particularly within urban healthcare systems. Both domestic and international medical device manufacturers continue to expand their presence by introducing technologically advanced and cost-effective implant solutions. Increasing patient awareness, improved physician training, and greater acceptance of surgical treatment for chronic knee disorders are further accelerating market growth.

In July 2023, Beijing Tinavi Medical Technologies Co., Ltd. received approval from China’s National Medical Products Administration (NMPA) for its Tirobot Recon robotic surgical system for total knee arthroplasty, expanding the company’s orthopedic robotics portfolio across spine, trauma, and joint replacement procedures.

Brazil Knee Replacement

Brazil’s knee replacement market is experiencing steady growth, supported by gradual improvements in healthcare infrastructure, increasing awareness of orthopedic treatment options, and a rising burden of degenerative joint diseases. An aging population, increasing obesity prevalence, and higher rates of osteoarthritis are driving demand for knee replacement procedures throughout the country. Although public hospitals continue to provide orthopedic surgical services, lengthy waiting periods have encouraged many patients to seek treatment through private healthcare providers. Expanding private health insurance coverage, growing investment in specialized orthopedic centers, and wider adoption of advanced implant technologies are supporting market development. Despite ongoing challenges related to procedure affordability and limited healthcare access in rural regions, continued expansion of urban healthcare facilities and minimally invasive surgical techniques is expected to sustain market growth.

United Arab Emirates Knee Replacement

The United Arab Emirates is emerging as a rapidly growing market for knee replacement procedures, supported by advanced healthcare infrastructure, increasing lifestyle-related musculoskeletal disorders, and the country’s expanding role as a regional medical tourism destination. Significant government investment in specialty hospitals and orthopedic centers equipped with state-of-the-art surgical technologies has strengthened access to high-quality orthopedic care. Rising obesity rates, sports-related injuries, and a growing elderly expatriate population continue to increase demand for knee replacement surgery. Patients in the UAE benefit from access to advanced implant systems, robotic-assisted surgical technologies, and comprehensive rehabilitation programs. Combined with the country’s strategic focus on becoming a regional center for advanced healthcare services, these factors are expected to support sustained growth of the UAE knee replacement market throughout the forecast period.

Market Segmentations

Product Type

• Total Knee Replacement
• Partial Knee Replacement
• Revision Knee Replacement

Implant Type

• Fixed Bearing Implants
• Mobile Bearing
• Others

End User

• Hospitals
• Orthopedic Clinics
• Ambulatory Surgery Center

Country

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Turkey

Asia Pacific

• China
• Japan
• India
• South Korea
• Thailand
• Malaysia
• Indonesia
• Australia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Key Players Analysis

• Zimmer Biomet Holdings, Inc.
• Stryker Corporation
• Smith & Nephew PLC
• Johnson & Johnson
• Conformis Inc
• Integra life sciences corporation
• MicroPort Scientific Corporation
• B. Braun Melsungen AG

Report Details: